集成学习结合临床、剂量与影像组学预测黑色素瘤脑转移立体定向放疗后局部失败
该多中心回顾性研究纳入130例患者的517个黑色素瘤脑转移灶,利用临床、剂量和疗前MRI影像组学数据构建集成学习模型预测立体定向放疗后局部失败。局部失败率为13.9%,基于影像组学的模型c-index为0.65,优于临床模型,但外部验证泛化性受限。
要点
- 疗前MRI影像组学特征,尤其是瘤周区域特征,对预测局部失败有潜在价值。
- 剂量学数据单独无预测作用,影像组学模型优于临床模型。
- 模型在不同外部数据集间泛化性差异大,受患者特征和成像协议影响。
核心结论
- 疗前MRI特征尤其是瘤周区域特征有望预测黑色素瘤脑转移立体定向放疗后病灶特异性结局。
- 结合临床数据可提供预后信息,但数据异质性限制泛化性。
研究设计与样本
- 多中心回顾性研究,纳入130例患者的517个黑色素瘤脑转移灶,接受单次或大分割立体定向放疗。
- 从增强T1加权MRI提取每个病灶1576个影像组学特征(GTV 788个,瘤周3mm 788个)。
- 使用一个中心的数据通过嵌套交叉验证进行特征选择和模型开发(集成学习方法),另两个中心数据用于外部验证。
主要发现
- 局部失败发生于72/517个病灶(13.9%)。
- 基于临床数据、影像组学特征及两者组合的模型c-index分别为0.60±0.15、0.65±0.11和0.65±0.12。
- 影像组学模型优于临床模型;剂量学数据单独无预测作用。
- 大多数有预测价值的影像组学特征来自瘤周区域(92%)而非GTV(76%)。
- 第一个外部数据集上所有模型表现相似(c-index:0.60–0.63),第二个数据集上泛化性差(c-index<0.50)。
关键数值与推荐
- 局部失败定义:原文未明确给出。
- 预测性能评价指标:c-index。
- 影像组学特征提取:增强T1加权MRI,GTV及瘤周3mm区域各788个特征。
临床怎么用
- 疗前MRI影像组学特征尤其是瘤周区域特征可作为黑色素瘤脑转移立体定向放疗后局部失败的预后参考。
- 剂量学数据单独不推荐用于预测局部失败。
- 结合临床数据与影像组学特征可提供额外预后信息,但需注意数据异质性对模型泛化性的影响。
局限性
- 回顾性研究设计。
- 外部验证泛化性受限,第二个数据集c-index<0.50,可能源于患者特征和成像协议差异。
- 数据异质性限制模型泛化性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to predict lesion-specific outcomes after stereotactic radiotherapy (SRT) in patients with brain metastases from malignant melanoma (MBM), using clinical, dosimetric, and pretherapeutic MRI data. METHODS: In this multicenter retrospective study, 517 MBM from 130 patients treated with single-fraction or hypofractionated SRT at three centers were analyzed. From contrast-enhanced T1-weighted MRI, 1576 radiomic features (RF) were extracted per lesion − 788 from the gross tumor volume (GTV) and 788 from a 3 mm peritumoral margin. Clinical, dosimetric and RF data from one center were used for feature selection and model development via nested cross-validation employing an ensemble learning approach; external validation used data from the other two centers. RESULTS: Local failure occurred in 72/517 lesions (13.9%). Predictive models based on clinical data, RF, or a combination of both achieved c-indices of 0.60 ± 0.15, 0.65 ± 0.11, and 0.65 ± 0.12, respectively. RF-based models outperformed the clinical models; dosimetric data alone were not predictive. Most predictive RF originated from the peritumoral margin (92%) versus GTV (76%). On the first external dataset, all models performed similarly (c-index: 0.60–0.63), but generalization was poor on the second (c-index < 0.50), likely due to differences in patient characteristics and imaging protocols. CONCLUSIONS: Pretherapeutic MRI features, particularly from the peritumoral region, show promise for predicting lesion-specific outcomes in MBM after SRT. Their consistent contribution suggests biologically relevant information that may support individualized treatment planning. Combined with clinical data, these markers offer prognostic insight, though generalizability remains limited by data heterogeneity. CLINICAL TRIAL NUMBER: Not applicable.
引用
- Wielenberg NE, Sachpazidis I, Blanck O, et al. Prediction of local failure after stereotactic radiotherapy in melanoma brain metastases using ensemble learning on clinical, dosimetric, and radiomic data. Radiat Oncol. 2026. PMID: 41864968. doi:10.1186/s13014-026-02825-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。